ArticleJournal of experimental & clinical cancer research : CR2022

Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis.

Inge Oudaert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.